Cite
HARVARD Citation
Molina-Pinelo, S. et al. (n.d.). 3041 Patient Derived Xenografts platform focused on developing effective anticancer agents for KRAS and FRFR1/4. European journal of cancer. pp. S609-S610. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Molina-Pinelo, S. et al. (n.d.). 3041 Patient Derived Xenografts platform focused on developing effective anticancer agents for KRAS and FRFR1/4. European journal of cancer. pp. S609-S610. [Online].